New Republic Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
New Republic Capital's BMY Position: Q2 2026 in Review
New Republic Capital opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 17,698 shares worth $1.02M. The stake represents 0.23% of the portfolio and ranks #84 among its holdings. This is a return to the name: New Republic Capital previously reported a position in BMY as recently as Q4 2025.
New Republic Capital first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,508 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- New Republic Capital held 17,698 shares of Bristol-Myers Squibb worth $1.02M as of Q2 2026.
- Bristol-Myers Squibb was a new New Republic Capital position in Q2 2026.
- Bristol-Myers Squibb made up 0.23% of New Republic Capital's portfolio in Q2 2026, its #84 holding.
- New Republic Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- 2,508 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on New Republic Capital's 13F filing for Q2 2026, filed 31 Jul 2026.